moclobemide has been researched along with Kidney Diseases in 1 studies
Moclobemide: A reversible inhibitor of monoamine oxidase type A; (RIMA); (see MONOAMINE OXIDASE INHIBITORS) that has antidepressive properties.
moclobemide : A member of the class of benzamides that is benzamide substituted by a chloro group at position 4 and a 2-(morpholin-4-yl)ethyl group at the nitrogen atom. It acts as a reversible monoamine oxidase inhibitor and is used in the treatment of depression.
Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Based upon the results of this study there does not appear to be any need to alter the normal dosing regimen of moclobemide in subjects with renal impairment in order to achieve drug concentrations similar to those in healthy subjects." | 1.28 | Disposition kinetics of moclobemide, a new MAO-A inhibitor, in subjects with impaired renal function. ( Frey, FJ; Horber, FF; Mayersohn, M; Schoerlin, MP, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schoerlin, MP | 1 |
| Horber, FF | 1 |
| Frey, FJ | 1 |
| Mayersohn, M | 1 |
1 other study available for moclobemide and Kidney Diseases
| Article | Year |
|---|---|
Disposition kinetics of moclobemide, a new MAO-A inhibitor, in subjects with impaired renal function.
Topics: Administration, Oral; Adult; Aged; Benzamides; Biological Availability; Female; Humans; Injections, | 1990 |